https://orcid.org/0000-0002-5323-0614
References
- Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379(2):198–205.
- Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149(6):565–574.
- Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma – evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111.
- Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215–1229.
- Rizvi S, Gores GJ. Emerging molecular therapeutic targets for cholangiocarcinoma. J Hepatol. 2017;67(3):632–644.
- Anderson C, Smitherman AB, Nichols HB. Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer. 2018;124(14):3037–3043.
- Chen Q-Y, Zhong Q, Zhou J-F, et al. Conditional survival and recurrence of remnant gastric cancer after surgical resection: a multi-institutional study. Cancer Sci. 2020;111(2):502–512.
- Hu L-S, Zhang X-F, Weiss M, et al. Redefining conditional overall and disease-free survival after curative resection for intrahepatic cholangiocarcinoma: a multi-institutional, international study of 1221 patients. J Gastrointest Surg. 2020;24(12):2756–2765.
- Latenstein AEJ, van Roessel S, van der Geest LGM, et al.; Dutch Pancreatic Cancer Group. Conditional survival after resection for pancreatic cancer: a population-Based study and prediction model. Ann Surg Oncol. 2020;27(7):2516–2524.
- Kim E, Koroukian S, Thomas CR Jr. Conditional survival of esophageal cancer: an analysis from the SEER registry (1988-2011). J Thorac Oncol. 2015;10(10):1490–1497.
- Spolverato G, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on cancer staging systems for intrahepatic cholangiocarcinoma. J Surg Oncol. 2017;115(6):696–703.
- Farges O, Fuks D, Le Treut Y-P, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer. 2011;117(10):2170–2177.
- Kim E, Thomas CR Jr. Conditional survival of malignant thymoma using national population-based surveillance, epidemiology, and end results (SEER) registry (1973-2011). J Thorac Oncol. 2015;10(4):701–707.
- Kawakami M, et al. Conditional survival and time of biochemical recurrence of localized prostate cancer in Japanese patients undergoing laparoscopic radical prostatectomies. Ann Surg Oncol. 2021;28(2):1247–1253.
- Jung S-Y, Jung K-W, Ha J, et al. Different patterns of conditional survival of breast cancer patients by age and histologic types: evidence from the Korean nationwide registry. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1169–1176.
- Yan X, Wang P, Zhu Z, et al. Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study. Future Oncol. 2019;15(18):2125–2137.
- Yuan L, Luo X, Lu X, et al. Liver resection for intrahepatic cholangiocarcinoma in AJCC‐stage IV: an evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification. Oncol Rep. 2016;36(5):2663–2672.
- Kong J, Cao Y, Chai J, et al. Effect of tumor size on long-term survival after resection for solitary intrahepatic cholangiocarcinoma. Front Oncol. 2020;10:559911.
- Kim Y, Moris DP, Zhang X-F, et al. Evaluation of the 8th edition American Joint Commission on cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol. 2017;116(6):643–650.
- Liu W, Luo Y, Wang G, et al. Conditional survival after surgery for patients with penile cancer. Andrology. 2020;8(6):1744–1752.
- Shao N, Wan F, Abudurexiti M, et al. Causes of death and conditional survival of renal cell carcinoma. Front Oncol. 2019;9:591.
- Zhong Q, Chen Q‐Y, Xie J‐W, et al. Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: a large population-based study. Cancer Med. 2018;7(7):3521–3533.